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Summary
Lipomannan (LM) and lipoarabinomannan (LAM) are
key Corynebacterineae glycoconjugates that are inte-
gral components of the mycobacterial cell wall, and
are potent immunomodulators during infection. LAM
is a complex heteropolysaccharide synthesized by an
array of essential glycosyltransferase family C (GT-C)
members, which represent potential drug targets.
Herein, we have identiﬁed and characterized two open
reading frames from Corynebacterium glutamicum
that encode for putative GT-Cs. Deletion of NCgl2100
and NCgl2097 in C. glutamicum demonstrated their
roleinthebiosynthesisofthebranchinga(1,2)-Manp
residues found in LM and LAM. In addition, utilizing
a chemically deﬁned nonasaccharide acceptor, azido-
ethyl 6-O-benzyl-a-D-mannopyranosyl-(1,6)-[a-D-
mannopyranosyl-(1,6)]7-D-mannopyranoside, and
the glycosyl donor C50-polyprenol-phosphate-[14C]-
mannose with membranes prepared from different C.
glutamicum mutant strains, we have shown that both
NCgl2100 and NCgl2097 encode for novel a(1,2)-
mannopyranosyltransferases, which we have termed
MptC and MptD respectively. Complementation
studies and in vitro assays also identiﬁed Rv2181 as a
homologue of Cg-MptC in Mycobacterium tuberculo-
sis. Finally, we investigated the ability of LM and LAM
from C. glutamicum, and C. glutamicumDmptC and C.
glutamicumDmptD mutants, to activate Toll-like recep-
tor 2. Overall, our study enhances our understanding
of complex lipoglycan biosynthesis in Corynebac-
terineae and sheds further light on the structural
and functional relationship of these classes of
polysaccharides.
Introduction
The Corynebacterineae, a sub-order of the Actinobacte-
ria, represent an unusual group within Gram-positive bac-
teria, with a distinctive cell wall architecture. Prominent
members are the human pathogens, Corynebacterium
diphtheriae, Mycobacterium tuberculosis and Mycobacte-
rium leprae (Bloom and Murray, 1992). Typically, the cell
walls of Corynebacterineae contain mycolic acids (m),
arabinogalactan (AG) and peptidoglycan (P), which are
covalently linked to each other to form the mycolyl-
arabinogalactan-peptidoglycan (mAGP) complex (Daffe
et al., 1990; McNeil et al., 1990; 1991; Besra et al.,
1995; 1997; Brennan, 2003; Dover et al., 2004). In addi-
tion, specialized glycophospholipids, phosphatidyl-myo-
inositol mannosides (PIMs) and lipoglycans, lipomannan
(LM) and lipoarabinomannan (LAM), are found in the
outer leaﬂet of mAGP (Hill and Ballou, 1966; Brennan and
Ballou, 1967; 1968; Brennan and Nikaido, 1995; Besra
et al., 1997; Morita et al., 2004). The non-pathogenic
bacillus, Corynebacterium glutamicum, also belongs to
this class of bacteria, and is widely used in the industrial
production of amino acids (Eggeling and Bott, 2005). Use
of this easily cultivatable bacterium, together with the fact
that the cell walls of Corynebacterineae share identical
basic structures and building blocks, have contributed
signiﬁcantly to decipher the biosynthesis of their complex
cell walls. For instance, in both C. glutamicum and M.
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(Gande et al., 2007) together with Pks (Gande et al.,
2004), are key to mycolic acid biosynthesis, and the gly-
cosyltransferases AftA (Alderwick et al., 2006a), and AftB
(Seidel et al., 2007a) introduce speciﬁc arabinofuranose
(Araf) residues into AG, and AftC in both AG and LAM of
Mycobacterium smegmatis (Birch et al., 2008; 2010). A
speciation-speciﬁc difference is the presence of the gly-
cosyltransferase RptA in C. glutamicum that introduces
decorating rhamnose residues into AG (Birch et al.,
2009), whereas a structurally very similar protein intro-
duces galactosamine residues into AG of M. tuberculosis
(Skovierova et al., 2010).
A particular interesting group of cell wall components
are the lipoglycans LM and LAM that are based on PIMs.
They play poorly deﬁned roles in Corynebacterineae but
mycobacterial LAM has been implicated in many of the
key aspects of the pathogenesis of tuberculosis and
leprosy, such as induction of phagocytosis, phagosomal
alteration and acquired T cell-mediated immunity (Briken
et al., 2004). Mycobacterial LAM has attached to the PIM
base, an elongated a(1→6) linear, a(1→2) branched
mannan ‘core’, of approximately 30 mannopyranose
(Manp) residues, and linked to its terminus a branched
D-arabinan domain. In mycobacteria, this large arabinan
domain consists of approximately 70 arabinofuranose
(Araf) residues and is assembled through several distinct
motifs (Chatterjee et al., 1991; Alderwick et al., 2007;
Birch et al., 2010), formed via speciﬁc a(1→5), a(1→3)
and b(1→2) arabinofuranosyltransferases (Besra et al.,
1997; Zhang et al., 2003; Alderwick et al., 2005; Birch
et al., 2010), and can be capped to various degrees with
either short a(1→2) mannopyranosyl chains, as is the
case in M. tuberculosis (Chatterjee et al., 1992), or in M.
smegmatis by inositol phosphate (Khoo et al., 1995), or
completely devoid of caps as found in Mycobacterium
chelonae (Guerardel et al., 2002). There is very limited
structural information on LAM in other Corynebacter-
ineae, except for C. glutamicum (Tatituri et al., 2007a,b).
In this organism the core a(1→6) linear a(1→2) branched
LM (see Fig. 9), which is structurally akin to mycobacterial
LM, is substituted by t-Araf residues to form a modiﬁed
LAM-like molecule (Tatituri et al., 2007a,b).
The current model of lipoglycan biosynthesis supported
by biochemical and genetic studies, follows a linear
pathway from PI→PIM2→LM→LAM (Besra and Brennan,
1997; Besra et al., 1997). As with AG synthesis selected
enzymatic and structural features are in part shared within
the Corynebacterineae. Glycosylation of phosphatidyl-
myo-inositol (PI) by different a-mannopyranosyl-
transferases and acylation by acyltransferase(s) results in
the synthesis of mono- and di-acylated PIMs (Kordula-
kova et al., 2002; 2003; Kremer et al., 2002; Morita et al.,
2006; Lea-Smith et al., 2008; Mishra et al., 2009). Previ-
ous studies have identiﬁed the enzymes involved in the
early and late stages of LM and LAM biosynthesis in
Corynebacterineae. For instance, NCgl1505/Rv1459c
(MptB) and NCgl2093/Rv2174 (MptA), synthesize the
proximal and distal a(1→6) mannan backbone in LM and
LAM (Kaur et al., 2007; Mishra et al., 2007; 2008a).
However, the enzymatic steps involved in the biosynthe-
sis of mannan branching of LM and LAM, still remain to be
studied in detail in Corynebacterineae (Kaur et al., 2006;
2008; Sena et al., 2010).
In the current study we have examined two open
reading frames from C. glutamicum, which encode for
putative glycosyltransferase family C (GT-C) members
(Liu and Mushegian, 2003). On the basis of mutant
studies, chemical and enzymatic data we report that
NCgl2100 (Cg-MptC) and its M. tuberculosis homologue
Rv2181 function as a(1→2)-mannopyranosyltrans-
ferases, and NCgl2097 functions as a second a(1→2)-
mannopyranosyltransferase (Cg-MptD), both of which are
required for complete mannose-branching found in LM
and LAM in Corynebacterineae.
Results
Genome locus and structural features of MptC
and MptD
We previously identiﬁed the a(1→6)-mannopy-
ranosyltransferases, MptA and MptB, which catalyse the
transfer of Manp residues from the glycosyl donor
C50-polyprenol-phosphate mannose, to the distal and
proximal ends of the mannan backbone of LM and LAM
respectively (Mishra et al., 2007; 2008a). In search of
further GT-Cs, which synthesize the elaborated structures
of LM and LAM, we interrogated the genome of C.
glutamicum for additional GT-C family members (Liu
and Mushegian, 2003). Located within a 16 kb genomic
region containing mptA, which has been demonstrated to
encode an a(1→2)-mannopyranosyltransferase in M.
tuberculosis (Kaur et al., 2008), as does its orthologue
MSMEG_4247 in M. smegmatis (Kaur et al., 2006; Sena
et al., 2010), are two additional GT-Cs (NCgl2100
[Cg-mptC], and NCgl2097 [Cg-mptD]) (Fig. 1A). In both
Corynebacterium and Mycobacterium additional genes
are retained at this locus: a serine/threonine protein
kinase (pknL), hypothetical proteins (NCgl2099, Rv2179c;
NCgl2094, Rv2175c) and a 3-deoxy-7-phospho-
heptulonate synthase (aroG) (Fig. 1A).
The Cg-mptC encoded protein is a long hydrophobic
polytopic membrane protein of 812 amino acid (aa)
residues. The ﬁrst half of the protein (1–417 aa), shares
37% identity (55% similarity) with Mt-MptC and 38% iden-
tity (57% similarity) to Cg-MptD, whereas the second half
(417–812 aa), has no counterpart in various Mycobacte-
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two membrane proteins, functional as an a(1→2)-
mannopyranosyltransferase as described below, and
termed in this study Cg-MptC. Cg-MptD is a hydrophobic
polytopic membrane protein of 436 amino acid residues
with 11 transmembrane helixes (TMH). After TMH-1
and TMH-7, larger loop regions are present probably
localized in the periplasm. Cg-MptC, Cg-MptD and
Mt-MptC, together with Mt-PimE, an a(1→2)-
mannopyranosyltransferase demonstrated to be involved
in PIM6 synthesis (Morita et al., 2006), share a similar
size, degree of hydrophobicity and regions of high identity
(Fig. 1B), suggesting closely related functions.
Construction of deletion mutants and growth phenotype
The construct pK19mobsacBDCg-mptC was made con-
taining 12 nucleotides (nt) of the 3′ end of NCgl2100
together with the genomic upstream sequences, and
36 nt of the 5′ end together with genomic downstream
sequences (Table S1). This non-replicative vector was
used to transform C. glutamicum to kanamycin-
resistance (Kanr) indicating chromosomal integration.
Sucrose-resistant (Sucr) clones were selected in a
second round of positive selection, indicating loss of the
vector-encoded sacB function (Schäfer et al., 1994).
From 12 Kans and Sucr clones analysed via PCR, seven
had lost NCgl2100, whereas in the remaining ﬁve the
genomic wild type situation was restored. One clone
with deleted NCgl2100 was selected and will be referred
to as C. glutamicumDmptC (Fig. S1) In an analogous
manner, pK19mobsacBDCg-mptD was constructed
and used to select from the wild type of C. glutamicum
by double cross-over events as described above for
deletion of Cg-mptD, yielding C. glutamicumDmptD
(Fig. S1). Starting from C. glutamicumDmptC and using
pK19mobsacBDCg-mptD the double deletion mutant
C. glutamicumDmptCDmptD was also constructed
(Fig. S1).
The mutants were inoculated into liquid BHI and CGXII
medium and their growth patterns studied. There was
no statistical difference observed in three independent
cultivations for each of the strains. The growth rates in
CGXII were 0.39  0.02 h-1 for wild-type C. glutamicum,
C. glutamicumDmptC and C. glutamicumDmptD, and
0.37  0.02 h-1 for C. glutamicumDmptCDmptD (data
not shown). The growth rates on BHI medium were
0.66  0.07 h-1 for all three strains and illustrate that the
genes are not essential for growth as observed for other
GT-Cs involved in mAGP synthesis like, Cg-emb,C g - aftA
and Cg-aftB (Alderwick et al., 2005; 2006a; Seidel et al.,
2007a).
Fig. 1. Comparative gene relatedness of a(1→2) and a(1→6) mannopyranosyltransferases.
A. The genomic region in selected Corynebacterianeae containing the GT-C mannosyltransferases MptA, MptC and MptD.
B. Partial sequence alignment of the strongly related a(1→2) mannosyltransferases Cg-MptC, Cg-MptD, Mt-PimE and Mt-MptC illustrating
conserved residues.
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lipoglycans from C. glutamicumDmptC and
C. glutamicumDmptD
Lipoglycans from wild-type C. glutamicum, C. glutamicum
DmptC and C. glutamicumDmptD with complemented
strains C. glutamicumDmptC pEKEx2-Cg-mptC, C.
glutamicumDmptC pEKEx2-Rv2181, C. glutamicumD-
mptD pEKEx2-Cg-mptD and C. glutamicumDmptD
pEKEx2-Rv2181, were extracted from delipidated cells by
ethanol/water extraction followed by hot-phenol water
treatment and enzymatic degradation. The crude lipogly-
can extract was subjected to hydrophobic interaction and
gel permeation chromatography allowing the separation
of Cg-LM (Cg-LM-A and Cg-LM-B) and Cg-LAM (Tatituri
et al., 2007b; Lea-Smith et al., 2008; Mishra et al.,
2008b). Because the mannan backbone structures of
Cg-LM-A and Cg-LM-B are similar as revealed through
previous matrix-assisted laser desorption/ionization time-
of-ﬂight mass spectrometry (MALDI-TOF-MS), and gas
chromatography-mass spectrometry (GC-MS) analyses
of partially methylated alditol acetates (Mishra et al.,
2008b), subsequent analyses focused on the Cg-LM as a
mixture. The extracted lipoglycans were examined for
their size and mobility on 15% SDS-PAGE (Fig. 2A). The
crude extracts from wild-type C. glutamicum showed the
presence of Cg-LM and Cg-LAM (Tatituri et al., 2007a;
Lea-Smith et al., 2008; Mishra et al., 2008b) (Fig. 2A),
while the crude lipoglycans from mutant strains, C.
glutamicumDmptC and C. glutamicumDmptD, showed
subtle differences in their migration on SDS-PAGE
(Fig. 2A). Puriﬁed Cg-LAM from C. glutamicumDmptC
and C. glutamicumDmptD (Fig. 2A) migrated faster on
SDS-PAGE in comparison with those from wild-type
C. glutamicum, indicating that these lipoglycans were
smaller in size with low molecular weights. In addition,
fractionation using gel permeation chromatography also
revealed a degree of heterogeneity in Cg-LM and
Fig. 2. Lipoglycan proﬁles of wild-type and mutant strains of C. glutamicum.
A. The left-hand and middle panels illustrate lipoglycans extracted from wild-type, mutant and complemented strains analysed using
SDS-PAGE and visualized using a Pro-Q emerald glycoprotein stain (Invitrogen). The right-hand panel illustrates puriﬁed Cg-LAM and Cg-LM
from C. glutamicumDmptC and C. glutamicumDmptD, respectively, in comparison with wild-type C. glutamicum lipoglycans. Lipoglycan proﬁles
are represented with standard molecular weight markers of glycoproteins of 180, 82, 42 and 18 kDa.
B. MALDI-TOF-MS spectra of Cg-LM and Cg-LAM from different strains of C. glutamicum. MALDI-TOF-MS spectra were acquired in the linear
negative mode with delayed extraction using 2,5-dihydrobenzoic acid as a matrix.
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mentation of C. glutamicumDmptC and C. glutamicumD-
mptD by pEKEx2-Cg-mptC and pEKEx2-Cg-mptD,
respectively, restored the wild-type phenotype, as illus-
trated by the slower and co-migration on SDS-PAGE
in comparison with wild-type C. glutamicum (Fig. 2A).
In contrast, cross-complementation experiments, C.
glutamicumDmptC by pEKEx2-Cg-mptD, and C. glutamic-
umDmptD by pEKEx2-Cg-mptC, failed to restore a wild-
type phenotype and reversion to a slower migration of
products on SDS-PAGE (Fig. S2), as observed in our
previous experiments described above (Fig. 2A).
The molecular weights of the lipoglycans were investi-
gated by MALDI-TOF-MS. The Cg-LAM from wild-type C.
glutamicum exhibited a broad unresolved peak centred at
m/z 15 000 (approximately 85 Manp/Araf glycosyl resi-
dues), and Cg-LM at m/z 5500 (approximately 25 Manp
residues), indicating a molecular weight of approximately
15 and 5.5 kDa for the major molecular species of these
lipoglycans (Fig. 2B). Interestingly, Cg-LAM from C.
glutamicumDmptC (Fig. 2A) peaked at m/z 13 800
(approximately 78 Manp/Araf glycosyl residues), indicat-
ing a decrease of around 1.2 kDa for the Cg-LAM isolated
from C. glutamicumDmptC as compared with wild-type
Cg-LAM (Fig. 2B). In addition, Cg-LM from C. glutamic-
umDmptC (Fig. 2A) exhibited a broad unresolved peak
centred at m/z 4400 (approximately 20 Manp glycosyl
residues), indicating a molecular weight of approximately
4.4 kDa, a decrease of 1.1 kDa in comparison with wild-
type C. glutamicum (Fig. 2B). Similarly, the lipoglycans,
Cg-LM and Cg-LAM from C. glutamicumDmptD (Fig. 2A)
are smaller and centred around m/z 13 000 (approxi-
mately 73 Manp/Araf glycosyl residues), and 4700
(approximately 20 Manp glycosyl residues) respectively
(Fig. 2B). The differences in size of Cg-LAM and Cg-LM
from the mutant strains, suggest that there is a difference
in a common component of both mutant strains, which
also reﬂects the earlier observation on SDS-PAGE
(Fig. 2A).
Glycosyl composition of puriﬁed lipoglycans from C.
glutamicumDmptC and C. glutamicumDmptD
Puriﬁed lipoglycans from wild-type C. glutamicum, C.
glutamicumDmptC and C. glutamicumDmptD were analy-
sed as alditol acetates and their glycosyl composition was
determined by gas chromatography (GC) (Fig. S3). GC
analysis of alditol acetates prepared from wild-type
Cg-LAM revealed a molar ratio of Araf :M a n p of 0.47:1.0.
The mutant Cg-LAM from C. glutamicumDmptC and C.
glutamicumDmptD yielded a signiﬁcant reduction in Manp
content concomitant with a relative increase in the amount
of Araf. The C. glutamicumDmptC yielded a mutant
Cg-LAM with an Araf :M a n p ratio of 0.59:1.0, while
Cg-LAM from C. glutamicumDmptD, yielded an Araf :
Manp ratio of 0.7:1.0. The data suggest that both
Cg-MptC and Cg-MptD are involved in the synthesis of
the mannan portion of Cg-LAM together with Cg-MptA
and Cg-MptB (Mishra et al., 2007; 2008a).
Glycosyl linkage of puriﬁed lipoglycans from C.
glutamicumDmptC and C. glutamicumDmptD
The glycosyl linkages present in the lipoglycans from wild-
type and mutant strains of C. glutamicum were analysed
by GC-MS of per-O-methylated alditol acetate derivatives
prepared from puriﬁed lipoglycans. Cg-LM from C.
glutamicum indicated a normal proﬁle of glycosidic link-
ages corresponding to t-Manp (49%), 6-Manp (15%),
2-Manp (6%) and 2,6-Manp (30%) (Fig. 3A). However, the
relative ratios of different linkages in Cg-LM from C.
glutamicumDmptC [t-Manp (23%), 6-Manp (58%), 2-Manp
(6%) and 2,6-Manp (13%)] and C. glutamicumDmptD
[(t-Manp (25%), 6-Manp (45%), 2-Manp (8%) and 2,6-
Manp (22%)] indicated subtle changes in the mannan
domain in Cg-LM from these strains consistent with the
earlier MALDI-TOF-MS data indicating a reduction in
size (Fig. 2B). The relative abundance of t-Manp and
2,6-Manp were reduced with a concomitant increase in
the abundance of 6-Manp in Cg-LM from these strains
(Fig. 3A). Similarly, per-O-methylated alditol acetate
derivatives of Cg-LAM from these strains showed a net
reduction in relative abundance of t-Manp and 2,6-Manp
and increase in 6-Manp (Fig. 3B). For instance, Cg-LAM
from C. glutamicum indicated a normal proﬁle of glyco-
sidic linkages corresponding to t-Araf (40%), t-Manp
(14%), 6-Manp (6%), 2-Manp (11%) and 2,6-Manp (29%)
(Fig. 3A). Whereas the relative ratios of different linkages
in Cg-LAM from C. glutamicumDmptC were t-Araf (40%),
t-Manp (6%), 6-Manp (30%), 2-Manp (11%) and 2,6-Manp
(13%) and C. glutamicumDmptD were t-Araf (40%),
t-Manp (8%), 6-Manp (26%), 2-Manp (12%) and 2,6-Manp
(14%). The complementation of C. glutamicumDmptC
and C. glutamicumDmptD with pEKEx2-Cg-mptC and
pEKEx2-Cg-mptD, respectively, restored the wild-type
phenotype in these strains (data not shown). Altogether,
the data together suggest that Cg-LM and Cg-LAM from
C. glutamicumDmptC and C. glutamicumDmptD have
reduced 2,6-Manp branching residues indicating that
MptC and MptD are involved in the synthesis of a(1→2)-
Manp residues in Cg-LM and Cg-LAM in C. glutamicum.
Characterization of Cg-LAM from
C. glutamicumDmptCDmptD
Because the data in Fig. 3A,B suggest that deletion of
mptC or mptD results in only partial removal of 2,6-Manp
branching residues, we constructed a C. glutamicumD-
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The extracted lipoglycans were examined for their size
and mobility on 15% SDS-PAGE (Fig. 4A). The crude
lipoglycan extracts of C. glutamicumDmptCDmptD in com-
parison with wild-type C. glutamicum, C. glutamicumD-
mptC and C. glutamicumDmptD, migrated faster on SDS-
PAGE, indicating that these lipoglycans were smaller in
size (Fig. 4A). The puriﬁed Cg-LAM from C. glutamicum-
DmptCDmptD was analysed by 1H-13C-NMR HMQC
(Fig. 4C) and compared with our previously reported
1H-13C-NMR HMQC (Fig. 4B) assignment of anomeric
resonances of Cg-LAM from C. glutamicum (Tatituri et al.,
2007b). Brieﬂy, correlations at dH1C1 5.20/112.2 and
5.13/112.0 were attributed to t-a-Araf units; 5.06/105.2 to
t-a-Manp units; 5.12/101.4, 5.07/10.1.7, and 5.04/101.9 to
2,6-a-Manp units; 4.93/102.6 to 6-a-Manp units; and
5.00/104.9 to 2-a-Manp units, which were consistent with
our above glycosyl linkage data for Cg-LAM from C.
glutamicum (Fig. 2B). In contrast, the 1H-13C-NMR HMQC
(Fig. 4C) of Cg-LAM from C. glutamicumDmptCDmptD
was dominated by a single anomeric resonance at dH1C1
4.92/102.5 and assigned to 6-a-Manp units, consistent
with a complete removal of 2,6-a-Manp branching
residues. GC-MS of per-O-methylated alditol acetate
derivatives from Cg-LAM puriﬁed from C. glutamicumD-
mptCDmptD conﬁrmed these results and the identiﬁcation
of 2,3,4-tri-O-CH3-1,5,6-tri-O-COCH3-mannitol with the
characteristic fragment alditol cleavage ions m/z 102, 118,
129, 162, 189 and 233 (Fig. S4).
In vitro a(1,2)-mannopyranosyltransferase assay
utilizing a novel blocked nonasaccharide acceptor
For characterization of a(1→2)-mannopyranosyl-
transferase activities of Cg-MptC and Cg-MptD a
nonasaccharide acceptor, azidoethyl 6-O-benzyl-a-D-
mannopyranosyl-(1→6)-[a-D-mannopyranosyl-(1→6)]7-
D-mannopyranoside, Acc-Man9 (Fig. 5A, compound 1)
was chemically synthesized (Fig. 5A,B). The synthesis of
the target nonamannopyranoside 1 was planned starting
from the previously synthesized 2 (Aqueel et al., 2008) via
synthesis of oligosaccharide 3 (Fig. 5A). For the synthesis
Fig. 3. Glycosyl linkage analysis of Cg-LM and Cg-LAM from different strains of C. glutamicum.
A. Cg-LM per-O-methylated samples were hydrolysed using 2 M TFA, reduced and per-O-acetylated. The resulting partially per-O-methylated,
per-O-acetylated alditol acetates were analysed using GC-MS.
B. Cg-LAM per-O-methylated samples were hydrolysed using 2 M TFA, reduced and per-O-acetylated. The resulting partially
per-O-methylated, per-O-acetylated alditol acetates were analysed using GC-MS. The partially per-O-methylated, per-O-acetylated alditol
acetates were identiﬁed based on their characteristic alditol cleavage acetal proﬁles: t-Araf (m/z 118, 161), t-Manp (m/z 118, 102, 145, 161,
162, 205), 2-Manp (m/z 129, 130, 161, 190), 6-Manp (m/z 118, 129, 162, 189, 233) and 2,6-Manp (m/z 129, 130, 189, 190).
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the reported 5,6-O-benzylidene protected thioglycoside 5
(Cumpstey et al., 2004) (Fig. 5B). In a straight forward
reaction sequence, thioglycoside 5 was treated with
benzoyl chloride in pyridine to access the thioglycoside 6,
which on regioselective ring opening with Et3SiH gave
6-OBn thioglycoside 7. The 1H NMR and 13C NMR spec-
tral studies conﬁrmed the structure of 7. An acetate pro-
tecting group was installed at the 4-OH position in
thioglycoside 7 by reacting with acetic anhydride in pyri-
dine resulting in the thioglycoside donor 4. An acetate
group was speciﬁcally chosen to easily characterize the
reaction product during coupling of 4 and 2 by NMR. The
donor thioglycoside 4 and 2 were coupled in the presence
of NIS and triﬂic acid at -20°C, resulting in nonasaccha-
ride 3 after chromatographic puriﬁcation. The observed
singlet signal in the 1H NMR spectrum of 3 at d 1.88 ppm
was assigned to the three protons of the acetyl protecting
group, and the resonances at d 4.48 and 4.28 ppm (dou-
blets, J = 11.9 Hz), for one proton each to the benzyl
protecting group, supporting the structure of 3. The 13C
NMR spectrum further conﬁrmed the structure of 3, with
the presence of signals at 73.45 and 20.81 ppm, which
were assigned to the CH2 of the benzyl and CH3 of the
acetyl carbons respectively. The ester protecting groups
in oligosaccharide 3 were removed in an overnight reac-
tion using sodium methoxide in CH3OH. The reaction was
neutralized using H+ Amberlite resin and the reaction
product puriﬁed using Bio-Beads SM-4 using a
CH3OH-H2O mobile phase and 0–60% gradient resulting
in the desired nonomannoside 1. The 1H NMR spectrum
of 1 showed the presence of benzyl signals at d 4.64 and
4.61 ppm (doublet, J = 11.7 Hz). In the 13C NMR spec-
trum, the benzyl carbon was observed at d 73.32 ppm and
CH2N3 at d 51.79 ppm. Finally, the structure of 1 was
further supported by HR-MS, which showed a [M + Na]+
peak at 1685.55.
The structural features of the acceptor allowed its spe-
ciﬁc isolation and puriﬁcation of in vitro reaction products
synthesized by distinct a(1→2)-mannopyranosyl-
transferases using a strong anion exchange cartridge,
thus removing from the in vitro assay unused C50-
polyprenol-phospho-[14C]-mannose (PP-[14C]-M) and
other in vitro synthesized products, such as higher
[14C]-PIMs, [14C]-LM and [14C]-LAM. In addition, the non-
reducing sugar of 1 (which we have abbreviated as
Acc-Man9) is blocked at the O-6 position by a benzyl
ether, thus preventing further elongation by endogenous
activities through MptA and MptB via a(1→6)-
mannopyranosyltransferases. Overall, the utilization of
Acc-Man9 and the in vitro assay provides a novel route to
evaluate distinct a(1→2)-mannopyranosyltransferases in
Corynebacterineae (Fig. 6A). The in vitro transfer of
[14C]-Manp from PP-[14C]-M onto the Acc-Man9 acceptor
was examined using membrane preparations from wild-
type and mutant strains of C. glutamicum (Fig. 6B). In this
improved assay, membrane preparations from wild-type
C. glutamicum transferred 3072  132 cpm of [14C]-Manp
Fig. 4. Lipoglycan analysis of C. glutamicumDmptCDmptD.
A. Lipoglycans were extracted from wild-type and mutant strains
and were analysed using SDS-PAGE and visualized using a Pro-Q
emerald glycoprotein stain (Invitrogen). Lipoglycan proﬁles are
represented with standard molecular weight markers of
glycoproteins of 180, 82, 42 and 18 kDa.
B. 2D
1H-
13C-NMR HMQC characterization of Cg-LAM from C.
glutamicum as described in Tatituri et al. (2007b).
C. 2D
1H-
13C-NMR HMQC characterization of Cg-LAM from C.
glutamicumDmptCDmptD. NMR spectra of Cg-LAMs were recorded
in D2O at 313 K.
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a(1→2)-mannopyranosyltransferase (Fig. 6B and inset).
Assays repeated in the absence of Acc-Man9 afforded
background activity 102  12 cpm, demonstrating the
efficiency of the assay (Fig. 6B). Membrane prepara-
tions from both C. glutamicumDmptC and C. glutamicum-
DmptD used in above assays afforded a(1→2)-
mannopyranosyltransferase activities, but in each case
the relative level of activity in comparison with wild-type C.
glutamicum membranes was reduced (Fig. 6B).
The analysis of [14C] reaction products was simpliﬁed
further by utilizing membrane preparations from the
branching deﬁcient double mutant, C. glutamicumD-
mptCDmptD, lacking Cg-MptC and Cg-MptD. The C.
glutamicumDmptCDmptD mutant possessed background
(149  15 cpm) incorporation of [14C]-Manp (Fig. 6B),
demonstrating the complete absence of a(1→2)-
mannopyranosyltransferase activity in this double mutant.
Therefore, the double mutant, C. glutamicumDmptCD-
mptD was used to analyse the enzymatic activities of
Cg-MptC and Cg-MptD. Cg-mptC and Cg-mptD were
cloned into pEKEx2 and introduced into C. glutamicumD-
mptCDmptD resulting in C. glutamicumDmptCDmptD
pEKEx2-Cg-mptC and C. glutamicumDmptCDmptD
pEKEx2-Cg-mptD. C. glutamicumDmptCDmptD pEKEx2-
Cg-mptC resulted in 1570  83 cpm of
Acc-Man9-[14C]-Manx, while C. glutamicumDmptCDmptD
pEKEx2-Cg-mptD resulted in 953  24 cpm of
Acc-Man9-[14C]-Manx.
Acc-Man9-[14C]-Manx selective cleavage by an
a(1,2)-D-mannosidase
The extracted Acc-Man9-[14C]-Manx reaction product from
the above assays performed with C. glutamicum mem-
branes (Fig. 6B) were dried and subsequently treated with
a previously characterized a(1→2)-D-mannosidase from
Trichoderma reesei (Maras et al., 2000) as described (Ich-
ishima et al., 1981; Yokoyama and Ballou, 1989) to deter-
mine the a(1→2) addition of Manp. The digested mixtures
were fractionated on a gel ﬁltration column. The control
Acc-Man9-[14C]-Manx reaction product, before a(1→2)-
D-mannosidase treatment eluted from the Bio-Gel
P-2 column at fractions 13–16, and this completely enzy-
matically digested product (measured through the release
of [14C]-Manp), was retained and eluted in later frac-
tions 35–42 with a [14C]-mannose standard (Fig. 6C;
Cooper et al., 2002). The results demonstrate that
the addition of [14C]-Manp to Acc-Man9 is via an a(1→2)-
mannopyranosyltransferase, and combined with the
data from Fig. 6B and the use of the C. glutamicumD-
mptCDmptD mutant strain, has shown that MptC
and MptD are solely responsible for this a(1→2)-
mannopyranosyltransferase activity.
Functional identiﬁcation of the mycobacterial homologue
of Cg-MptC
As described above (Fig. 1), Cg-MptC showed highest
similarity of 55% to Rv2181 of M. tuberculosis, while
Fig. 5. Chemical synthesis of the nonasaccharide acceptor azidoethyl
6-O-benzyl-a-D-mannopyranosyl-(1→6)-[a-D-mannopyranosyl-(1→6)]7-D-mannopyranoside (1) and key intermediate 4. Reagents and
conditions.
A. (a) NIS, triﬂic acid, CH2Cl2, -20°C–0°C, 1 h, 82%; (b) Sodium methoxide, CHCl3-CH3OH (1:2), overnight, 35%;
B. (a) BzCl, pyridine, room temperature, 4 h, 94%; (b) Et3SiH, triﬂic acid, CH2Cl2, -78°C, 1 h, 80%; (c) acetic anydride, pyridine, room
temperature, 5 h, 94%.
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47.9% to Rv2181. To assay for a complementary function
of Rv2181 in C. glutamicum, plasmid pEKEx2-Mt-Rv2181
was constructed. Upon introduction into C. glutamicumD-
mptC, the wild-type phenotype of C. glutamicum was
restored (Fig. 2A) illustrating that Mt-MptC is functional
and utilizes the corynebacterial substrates. In addition,
Rv2181 was very speciﬁc for C. glutamicumDmptC as
complementation of the mutant phenotype in C. glutamic-
umDmptD was not obtained (Fig. 2A). The complementa-
tion of C. glutamicumDmptC with pEKEx2-Mt-Rv2181
also restored the wild-type glycosyl linkage phenotype in
this strain (Fig. 7, and see Fig. 3A and B). Furthermore,
use of membrane preparations from C. glutamicumD-
mptCDmptD pEKEx2-Mt-Rv2181 and the synthetic
Acc-Man9 (Fig. 6A) resulted in the incorporation of
1811  87 cpm of [14C]-Manp into the [14C]-mannan
product (Fig. 6B). Altogether, these data strongly suggest
that Rv2181 is a homologue of Cg-mptC and both encode
for a(1→2)-mannopyranosyltransferase activities,
involved in the synthesis of the a(1→2)-Manp branches of
LM and LAM in Corynebacterineae.
Activation of Toll-like receptor 2 (TLR2) by wild-type and
mutant Cg-LM and LAM
Both LM and LAM are bioactive molecules thought to be
involved in modulating the host immune response (Briken
et al., 2004). Bacterial lipoglycans are recognized by a
variety of host immune receptors including TLR2. In fact,
mycobacterial LMs are well known to be potent activators
of this latter receptor hence providing them strong pro-
inﬂammatory activity (Vignal et al., 2003; Quesniaux
et al., 2004; Gilleron et al., 2006). On the other hand,
Fig. 6. In vitro a(1→2)-
mannopyranosyltransferase assay utilizing a
nonasaccharide acceptor.
A. Reaction scheme illustrating in vitro assays
performed with the chemically synthesized
nonasaccharide acceptor, azidoethyl
6-O-benzyl-a-D-mannopyranosyl-(1→6)-[a-
D-mannopyranosyl-(1→6)]7-D-
mannopyranoside, Acc-Man9, and either MptC
or MptD, resulting in the synthesis of
Acc-Man9-[
14C]-Manx.
B. The reactions were set up with and without
Acc-Man9 (+ or -), PP-[
14C]-M, and membrane
preparations from different strains of C.
glutamicum as described in the Experimental
procedures.
C. The Acc-Man9-[
14C]-Manx product from the
use of C. glutamicum membranes was dried
and subsequently incubated with an
a(1→2)-mannosidase. The reaction mixture
was then fractionated on a Bio-Gel P-2 gel
ﬁltration column. The control
Acc-Man9-[
14C]-Manx (dotted line) product
before a(1→2)-D-mannosidase treatment
eluted from the Bio-Gel P-2 column at
fractions 11–13, and the digested product,
released [
14C]-Man (solid line), was retained
and eluted in later fractions 33–39, co-eluting
with a [
14C]-mannose standard (Cooper et al.,
2002).
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presence of the arabinan domain that masks the ‘bioac-
tive’ mannan core (Vignal et al., 2003; Nigou et al., 2008;
Birch et al., 2010). To investigate the ability of Cg-LM and
Cg-LAM to activate TLR2 to assess possible conse-
quences of Cg-mptC and Cg-mptD inactivation in this
process, puriﬁed LM and LAM from C. glutamicumDmptC
and C. glutamicumDmptD, were used to stimulate
HEK293 cells expressing TLR2. To prevent interference of
co-puriﬁed lipopeptides, the glycolipids were ﬁrst pre-
treated with hydrogen peroxide (Morr et al., 2002; Geurt-
sen et al., 2009; Birch et al., 2010). As shown in Fig. 8,
wild-type Cg-LAM was unable to activate TLR2. This
result is consistent with an earlier study in which it was
shown that LAMs substituted with single arabinosyl resi-
dues were unable to induce the production of tumour
necrosis factor-a in human THP-1 monocytes (Nigou
et al., 2008). Interestingly, LAMs isolated from the C.
glutamicumDmptC and C. glutamicumDmptD mutant
strains demonstrated an increased activity as evidenced
by the enhanced TLR2-dependent IL-8 production by
HEK293 cells (Fig. 8). This suggests that partial removal
of a(1→2)-Manp units, increases the ability of Cg-LAM to
activate TLR2. In contrast to mycobacterial LMs, wild-type
Cg-LM did not show any activity towards TLR2. Further-
more, mutation of Cg-mptC and Cg-mptD did not alter this
behaviour and the mutant LMs remained inactive (Fig. 8).
These results demonstrate that wild-type Cg-LAM and
Cg-LM, are both TLR2 inactive. Furthermore, partial
removal of a(1→2)-Manp branching may promote TLR2
activation, but this is only the case for Cg-LAM.
Discussion
Apart from sharing a similar cell wall architecture, C.
glutamicum possesses similar genetic loci responsible for
cell wall biosynthesis like M. tuberculosis. As a model, it
has proven extremely useful in the study of essential
genetic elements of M. tuberculosis (Alderwick et al.,
Fig. 7. Characterization of the mycobacterial homologue Rv2181
of Cg-MptC. Lipoglycans were extracted from C. glutamicumDmptC
pEKEx2-Mt-Rv2181, and the resulting Cg-LM and Cg-LAM
products puriﬁed, per-O-methylated, and hydrolysed using 2 M
TFA, reduced and per-O-acetylated. The resulting partially
per-O-methylated, per-O-acetylated alditol acetates were analysed
by GC-MS and products identiﬁed based on their characteristic
alditol cleavage acetal proﬁles: t-Araf (m/z 118, 161), t-Manp (m/z
118, 102, 145, 161, 162, 205), 2-Manp (m/z 129, 130, 161, 190),
6-Manp (m/z 118, 129, 162, 189, 233) and 2,6-Manp (m/z 129,
130, 189, 190).
Fig. 8. TLR-2 stimulation by wild-type and
mutant Cg-LM and Cg-LAM. HEK293 cells
transfected with TLR2 were stimulated with
50 mgm l
-1 of wild-type (WT) or mutant
(DmptC/DmptD) Cg-LAM or Cg-LM.
Unstimulated cells (-) served as a control.
After 24 h of stimulation (37°C), supernatants
were harvested and analysed for IL-8 content
using ELISA. The results represent the mean
IL-8 production  SD from three independent
experiments (each experiment was performed
in triplicate). Double asterisks indicate highly
signiﬁcant (P < 0.001) differences as
compared to the unstimulated control cells.
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suitable model for the identiﬁcation and functional study of
mycobacterial genes involved in mycolic acid (Gande
et al., 2004; 2007), arabinogalactan (Alderwick et al.,
2005; 2006b; 2007; Seidel et al., 2007a,b; Birch et al.,
2008; 2009) and LAM biosynthesis (Gibson et al., 2003;
Mishra et al., 2007; 2008a,b; 2009; Tatituri et al.,
2007a,b). Previously, we reported the identiﬁcation of
enzymes involved in early and late stages of LM and LAM
biosynthesis in Corynebacterineae (Mishra et al., 2007;
2008a,b; 2009).
SDS-PAGE and MALDI-TOF-MS analysis of different
lipoglycan species, including Cg-LM and Cg-LAM from C.
glutamicumDmptC and C. glutamicumDmptD, suggested
that there is a difference in a similar component of all
these species. Two-dimensional thin-layer chromatogra-
phy (2D-TLC) analysis supplemented with negative
MALDI-TOF-MS of extracted glycolipids from mutants
failed to show any differences in the PIM precursors (data
not shown), and the presence of MptA and MptB in these
mutants, negates the possibility of a change in the
a(1→6) mannan backbone of these lipoglycans, leaving
the only possibility of a change in a(1→2)-Manp branch-
ing, suggesting that MptC and MptD are involved in syn-
thesis of these a(1→2)-Manp units in these lipoglycans. In
addition, glycosyl linkage analysis revealed a reduction
in the relative abundance of t-Manp and 2,6-Manp with
a concomitant increase in the abundance of 6-Manp
in Cg-LM and Cg-LAM from these strains. The cumula-
tive chemical analysis of C. glutamicumDmptC and C.
glutamicumDmptD agrees with the view that Cg-MptC and
Cg-MptD are involved in synthesis of a(1→2)-Manp units
in Cg-LM and Cg-LAM in C. glutamicum. This view was
strengthened by the analysis of a C. glutamicumDmptCD-
mptD double mutant and the speciﬁcity of MptC and MptD
in cross-complementation studies (Fig. S2). In summary,
the data clariﬁed the occurrence of residual t-a-Manp,
a(1→2)-Manp and t-a-Araf units in the Cg-MptC and
Cg-MptD mutants, as the singular mutants only partially
removed 2,6-Manp branching. The absence of these
units in the C. glutamicumDmptCDmptD mutant provides
evidence that these units are present as t-a-Manp-
(a1→2)-Manp and t-a-Araf-(a1→2)-Manp motifs (Fig. 9).
Furthermore, speciﬁc in vitro assays utilizing a chemically
synthesized nonasaccharide acceptor demonstrate that
both Cg-mptC and Cg-mptD encode for a(1→2)-
mannopyranosyltransferases, responsible for the synthe-
sis of the a(1→2)-Manp units on the mannan backbone of
Fig. 9. Biosynthetic pathway of LM (A) and LAM (B) biogenesis in Corynebacterineae. Cg-LM biosynthesis initially involves the formation of
the a(1→6) mannan backbone by MptB, followed by a(1→2)-Manp branching by MptC (or MptD). This biosynthetic precursor would then be
the substrate for further a(1→6)-Manp elongation by MptA, followed by a(1→2)-Manp branching by MptD (or MptC) to afford initially Cg-LM
(A). Further extension by MptA along with additional GT-C glycosyltransferases further modify the a(1→6)-mannan backbone. These GT-Cs
include MptC/D and MptE (formation of the dimannoside side-chain), and AftE/MptC/D and formation of Araf-Manp side-chains (B).
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et al., 2008), and the fact that Cg-MptC and Rv2181 are
homologues, it is tempting to speculate that Cg-MptC
adds a(1→2)-Manp residues to the proximal backbone of
Cg-LM, or one could imply that Rv2181 in vitro has MptC
function. A plasmid encoding Rv2181 was used to trans-
form the C. glutamicum mutants, and Rv2181 was able to
restore the wild-type phenotype in only the C. glutamic-
umDmptC mutant, and possessed a(1→2)-
mannopyranosyltransferase activity in the deﬁned in vitro
acceptor assay reported in this study.
Whereas the LM/LAM backbone is potentially rather
similar within the Corynebacterineae, as indicated
also from the relatedness of the a(1→6)-mannopy-
ranosyltransferases (Fig. 1), it is clear from structural,
immunological and genetic evidence, that the more elabo-
rated structures and decorations of these glycolipids are
variable. Known structural variations include large arabi-
nan domains in M. tuberculosis (Chatterjee et al., 1991;
McNeil et al., 1994), Man-capping of arabinan domains in
M. tuberculosis (Chatterjee et al., 1992) and their PI
capping in M. smegmatis (Khoo et al., 1995). Accordingly,
also immunological properties of LM/LAM are different
(Briken et al., 2004). This variability is naturally reﬂected
at the genetic level. An example is the capping GT-C
transferase of M. tuberculosis encoded by Rv1635c
(Appelmelk et al., 2008), which is not present in C.
glutamicum. The fact that MptC in C. glutamicum is a
fusion protein carrying a second domain with unknown
function, also illustrates that mature LM and LAM glycolip-
ids are species-speciﬁc and accordingly the correspond-
ing biosynthesis genes more prone to rapid evolution.
Duplication or fusion of genes may indicate that the types
of enzymes involved in the later steps of LM and LAM
synthesis are highly dynamic and of evolutionary change
within the Corynebacterineae (Xie et al., 2003).
A key question in lipoglycan biosynthesis is the division
of LM and LAM abundance in the cell wall. The separation
of LM and LAM in C. glutamicum, biosynthetically prob-
ably occurs after the initial formation of the a(1→6)
mannan backbone by MptB, followed by a(1→2)-Manp
branching by MptC (or MptD). The product of these two
enzymes would then be the preferred substrate for further
a(1→6)-Manp elongation by MptA, followed by a(1→2)-
Manp branching by MptD (or MptC) (Fig. 9). Additional
GT-C glycosyltransferases remain to be characterized
involved in further modiﬁcation of the a(1→6)-mannan
backbone. These include how the dimanoside (via MptE?)
and Araf-Manp side-chains are synthesized (AftE?) and
are summarized in Fig. 9.
Both LAM and LM are immunomodulatory molecules
(Briken et al., 2004). Whereas LAM has an important role
during intracellular survival, for instance by preventing
phagosome-lysosome fusion (Fratti et al., 2003), LM has
strong pro-inﬂammatory activity through its ability to acti-
vate TLR2 (Vignal et al., 2003; Quesniaux et al., 2004;
Gilleron et al., 2006). Previous research has demon-
strated that the pro-inﬂammatory activity of LM is at least
partly based upon its acylation status (Gilleron et al.,
2006; Doz et al., 2007). PI-based LAM and LM species
can differ in their degree of acylation, each carrying
between one and four acyl chains. Investigation of the
immune activating properties of differentially acylated LM
species demonstrated that LM should at least be tri-
acylated to be pro-inﬂammatory, with species carrying
less acyl chains exhibiting immunosuppressive activity in
a mechanism independent of TLR2 (Doz et al., 2007).
Here we investigated different Cg-LAM and LM species
for their ability to activate TLR2. Similar to mycobacterial
LAMs, wild-type Cg-LAM was found to be inactive (Fig. 8).
This ﬁnding is consistent with previous observations that
LAM species carrying only t-Araf substitutions, such as
LAMs isolated from Rhodococcus ruber and Turicella otiti-
dis, are largely inactive (Nigou et al., 2008). Comparison
of wild-type Cg-LAM to the LAMs isolated from the C.
glutamicumDmptC and C. glutamicumDmptD mutant
strains demonstrated that the mutant LAMs had gained
the ability to activate TLR2 (Fig. 8). The explanation for
this increased activity is currently not known. Interestingly,
wild-type Cg-LM, like wild-type Cg-LAM, but unlike myco-
bacterial LM was found to be completely TLR2-inactive
(Fig. 8). The reason for the discrepancy is unclear, but
may be related to structural differences in their membrane
anchors. In mycobacteria, LAMs and LMs share a
common PI anchor, on which further assembly occurs to
give mature LM and LAM. However, in C. glutamicum,
although Cg-LAM contains a normal PI anchor, two differ-
ent pools of Cg-LM (Cg-LM-Aand Cg-LM-B) dominate the
majority of lipoglycan composition of the corynebacterial
cell wall (Tatituri et al., 2007a; Lea-Smith et al., 2008;
Mishra et al., 2008b). The large majority of the Cg-LM
species (~95%), Cg-LM-B, contains an anchor based
upon a di-acylated a-D-glucopyranosyluronic acid-(1→3)-
glycerol moiety, and only a minor fraction contains the
more classical anchor based on PI, Cg-LM-A (Mishra
et al., 2008b). Despite the different lipid anchors, the
mannan backbone structures of Cg-LM-A and Cg-LM-B
are similar as revealed through GC-MS analysis of par-
tially methylated alditol acetates (Mishra et al., 2008b).
This means that the majority of Cg-LM species will contain
a di-acylated GlcAGroAc2 anchor, which is a feature that
has been demonstrated to be incompatible with activation
of TLR2 (Doz et al., 2007).
Furthermore, a complete investigation of the structural
and functional relationship of these lipoglycans during
host–pathogen interaction requires the availability of
mutants defective in their respective biosynthetic path-
ways. The availability of complete genome sequences of
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glutamicum, and the development of novel tools for
genetic manipulation has opened up these possibilities
(Cole et al., 1998).
Experimental procedures
Bacterial strains, cell culture and growth conditions
Corynebacterium glutamicum and E. coli DH5amcr were
grown in LB broth at 30°C and 37°C respectively. For C.
glutamicum complex medium BHI and minimal medium
CGXII was used (Eggeling and Bott, 2005). Kanamycin and
ampicillin were used at a concentration of 50 mgm l
-1 for
selection of recombinants. Samples for lipid analysis were
prepared by harvesting cells at an OD of 10–15, followed by
a saline wash and freeze drying. HEK293 cells transfected
with TLR2 (Flo et al., 2002) were kept in DMEM (Invitrogen)
containing 10% FCS, 100 U ml
-1 penicillin, 100 mgm l
-1 strep-
tomycin, 0.5 mg ml
-1 G418, 2 mM L-glutamine and 110 mg l
-1
pyruvate.
Construction of plasmids and strains
To delete Cg-mptC and Cg-mptD the deletion vectors
pK19mobsacBDCg-mptC, and pK19mobsacBDCg-mptD
were constructed. In each case cross-over PCR was used
with genomic DNA as template and two different PCR’s with
primer pairs AB and CD (Table S1). The resulting PCR prod-
ucts served as template for primer pairs AD. The PCR
product contained 12 nucleotides (nt) of the 3′ end of the
respective gene together with genomic upstream sequences,
and 36 nt of the 5′ end together with genomic downstream
sequences. The inserts of all plasmids used in this work were
conﬁrmed by sequencing. Genes were deleted in by ﬁrst
introducing plasmids prepared from E. coli via electroporation
into C. glutamicum and then selection for sucrose resistance
in a procedure as described (Schäfer et al., 1994). Starting
from C. glutamicumDmptC and using pK19mobsacBDCg-
mptD the double deletion mutant C. glutamicumDmptCDmptD
was made. The starting strain used was the type strain C.
glutamicum ATCC13032. Chromosomal deletions were con-
ﬁrmed using primer pairs AD, as well as the additional new
primer pairs EF, hybridizing outside of the regions used for
plasmid constructions.
To assay for complementation of chromosomal deletions
four expression plasmids were used. To construct pEKEx2-
Cg-mptC primer pairs Ex-2100-RBS-for and Ex-2100-rev
were used to amplify the 5′ half of NCgl2100, the PCR
product treated with SalI/EcoRI and ligated with similar
treated pEKEx2. To construct pEKEx2-Cg-mptD primer pairs
Ex-2097-RBS-for and Ex-2097-rev were used to amplify
NCgl2097, the PCR product treated with SalI/EcoRI and
ligated with similar treated pEKEx2. To construct pEKEx2-Mt-
Rv2181, chromosomal DNA of M. tuberculosis served as
template, and Rv2181 was ampliﬁed using primer pairs
Ex-Rv2181-for and Ex-Rv2181-rev, the former providing the
sequence CTGCAG as a ribosome binding site. The ampli-
ﬁed product was treated with PstI and EcoRI and ligated with
pEKEx2. Plasmids were used to transform the respective
mutants via electroporation to kanamycin resistance, and
recombinants conﬁrmed by plasmid preparation.
Lipid extraction and analysis
Polar and apolar lipids were extracted as described by
Dobson et al. (1985). Brieﬂy, 6 g of dry C. glutamicum cells
was treated in 220 ml of methanolic saline (20 ml 0.3% NaCl
and 200 ml CH3OH) and 220 ml of petroleum ether for 2 h
(Dobson et al., 1985). The suspension was centrifuged and
the upper layer containing apolar lipids was separated. An
additional 220 ml of petroleum ether was added, mixed and
centrifuged as described above. The two upper petroleum
ether fractions were combined and dried. For polar lipids,
260 ml CHCl3/CH3OH/0.3% NaCl (9:10:3, v/v/v) was added to
the lower aqueous phase and stirred for 4 h. The mixture was
ﬁltered and the ﬁlter cake re-extracted twice with 85 ml of
CHCl3/CH3OH/0.3% NaCl (5:10:4, v/v/v). Equal amounts of
CHCl3 and 0.3% NaCl (145 ml each) were added to the
combined ﬁltrates and stirred for 1 h. The mixture was
allowed to settle, and the lower layer containing the polar
lipids recovered and dried. The polar lipid extract was exam-
ined by 2D-TLC on aluminium backed plates of silica gel 60
F254 (Merck 5554), using CHCl3/CH3OH/H2O (65:25:4, v/v/v)
in the ﬁrst direction and CHCl3/CH3COOH/CH3OH/H2O
(40:25:3:6, v/v/v/v) in the second direction. The thin-layer
chromatographic plates sprayed with the appropriate staining
solution to detect the presence of lipids, glycolipids or phos-
pholipids as described (Dobson et al., 1985).
Extraction and puriﬁcation of lipoglycans
Lipoglycans were extracted from delipidated cells as previ-
ously described (Ludwiczak et al., 2001). Brieﬂy, cells were
broken by sonication (MSE Soniprep 150, 12 micron ampli-
tude, 60 s ON, 90 s OFF for 10 cycles, on ice) and the cell
debris reﬂuxed ﬁve times with 50% C2H5OH at 68°C, for 12 h
intervals. The cell debris was removed by centrifugation and
the supernatant containing lipoglycans, neutral glycans and
proteins dried. This dried extract was then treated with hot
phenol–H2O. The aqueous phase was dialysed and dried,
followed by extensive treatments with a-amylase, DNase,
RNase chymotrypsin and trypsin. This fraction was dialysed
to remove the low MW break-down products formed after the
enzyme treatment, thus yielding the crude lipoglycan fraction.
The crude lipoglycan extract was dried and resuspended in
buffer A (50 mM ammonium acetate and 15% propan-1-ol)
and subjected to Octyl Sepharose CL-4B chromatography
(2.5 ¥ 50 cm). The column (2.5 ¥ 50 cm) was washed initially
with four column volumes of buffer A to ensure removal of
neutral glycans followed by buffer B (50 mM ammonium
acetate and 50% propan-1-ol). The eluent was collected and
concentrated to approximately 1 ml and precipitated using
5 m lo fC 2H5OH. The sample was dried using a Savant
Speedvac and then resuspended in buffer C [0.2 M NaCl,
0.25% sodium deoxycholate (w/v), 1 mM EDTA and 10 mM
Tris-HCl, pH 8] to a ﬁnal concentration of 20 mg ml
-1. The
sample was gently mixed and left to incubate for 48 h at room
temperature. The sample was then loaded onto a Sephacryl
S-200 (2.5 cm ¥ 50 cm) column previously equilibrated with
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ﬂow rate of 3 ml h
-1, collecting 1.5 ml fractions. The fractions
were monitored by SDS-PAGE using either a silver stain or a
Pro-Q emerald glycoprotein stain and individual fractions
pooled and dialysed extensively against buffer D (10 mM
Tris-HCl, pH 8, 0.2 M NaCl, 1 mM EDTA) for 72 h with fre-
quent changes of buffer. The samples were further dialysed
against deionized water for 48 h with frequent changes of
water, lyophilized and stored at -20°C.
MALDI-TOF-MS and NMR analysis
The matrix used was 2,5-dihydroxybenzoic acid at a concen-
tration of 10 mg ml
-1, in a mixture of H2O/C2H5OH (1:1, v/v),
0.1% triﬂuoroacetic acid (TFA). Samples (0.5 ml) at a concen-
tration of 10 mg ml
-1 were mixed with 0.5 ml of the matrix
solution. Analyses were performed on a Voyager DE-STR
MALDI-TOF instrument (PerSeptive Biosystems, Framing-
ham, MA, USA) using linear mode detection. Mass spectra
were recorded in the negative mode using a 300 ns time
delay with a grid voltage of 80% of full accelerating voltage
(25 kV) and a guide wire voltage of 0.15%. The mass spectra
were mass assigned using external calibration. NMR spectra
of LAM samples were recorded on a Bruker DMX-500
equipped with a double-resonance (
1H/X)-BBi z-gradient
probe head. All samples were exchanged in D2O, with inter-
mediate lyophilization, and then dissolved in 0.7 ml D2O and
analysed at 313 K. The
1H and
13C NMR chemical shifts
were referenced relative to internal acetone at 2.225 and
34.00 ppm respectively. All details concerning NMR
sequences and the experimental procedures were described
previously (Tatituri et al., 2007b).
Glycosyl compositional and linkage analysis
Lipoglycans were hydrolysed using 250 mlo f2 MT F Aa t
120°C for 2 h, reduced with 100 ml of NaBD4 (10 mg ml
-1 in
C2H5OH:1 M NH4OH), and the resultant alditols per-O-
acetylated using acetic anhydride (100 ml) at 120°C for 1 h,
before examination by GC (Tatituri et al., 2007b). GC was
performed using a Thermoquest Trace GC 2000 and a
DB225 column (Supelco) with samples injected in the split-
less mode. The oven was programmed to hold at an isother-
mal temperature of 275°C for a run time of 15 min. Glycosyl
linkage analyses were performed as described previously
(Tatituri et al., 2007b). Brieﬂy, lipoglycan samples were per-
O-methylated using dimethyl sulﬁnyl carbanion, hydrolysed
using 2 M TFA, reduced using NaB2H4, and per-O-acetylated
before analysis by GC-MS (Tatituri et al., 2007b). GC-MS
was carried out on a Finnigan Polaris GCQ PlusTM using a
BPX5 (Supleco) column. The injector temperature was set
at 50°C, held for 1 min and then increased to 110°C at
20°C min
-1. The oven was held at 110°C then ramped to
290°C at 8°C min
-1 and held for 5 min to ensure all the
products had eluted from the column. All the data were col-
lected and analysed using Xcaliber (v.1.2) software.
General methods for chemical synthesis of Acc-Man9
(compound 1)
Reactions were performed under a dry argon atmosphere.
Whenever necessary, compounds and starting materials
were dried by azeotropic removal of water with toluene under
reduced pressure. The reactions were monitored by TLC on
pre-coated silica gel (60F254) plates (0.25 mm) from E. Merck
and visualized using UV light (254 nm) and/or heating after
spraying with (NH4)2SO4 solution (150 g ammonium sulphate,
30 ml H2SO4, 750 ml H2O). Flash column chromatography
was carried out on Isco Teledyne CombiFlash Rf200 chro-
matographic system using pre-packed columns.
1H and
13C
NMR spectra were recorded at 400 MHz and 100 MHz,
respectively, on a Varian 400-MR spectrometer. Coupling
constants (J) are reported in Hz and chemical shifts (d)i n
ppm relative to a residual solvent peak or an internal standard
(TMS). The HR-MS spectra were recorded on a Agilent 6140
liquid chromatography mass spectrometry instrument.
p-Tolyl 2,3-Di-O-benzoyl-4,5-O-benzylidene-1-thio-a-D-
mannopyranoside (6)
Compound 5 (230 mg, 0.61 mmol) was dissolved in 5 ml of
anhydrous pyridine, and benzoyl chloride (179 ml, 1.54 mmol)
was added dropwise. The reaction mixture was stirred for 4 h
at room temperature, poured into ice-water (15 ml) and
extracted with CHCl3 (2 ¥ 10 ml). The combined CHCl3
layers were washed with brine, dried over Na2SO4 and
concentrated. Flash chromatographic puriﬁcation of the
crude product using cyclohexane/ethyl acetate as eluent
gave pure 6 (335 mg, 94%) as a colourless solid (mp 66°C).
Rf = 0.44 (cyclohexane/ ethyl acetate, 2:1).
1H NMR (CDCl3,
400 MHz): d 8.06 (2H, m, Ar), 7.92 (2H, m, Ar), 7.61 (1H, m,
Ar), 7.46 (8H, m,Ar), 7.33 (4H, m,Ar), 7.15 (2H, d, J = 6.3 Hz,
Ar), 5.95 (1H, dd, J = 0.9, 2.7 Hz, H-2), 5.82 (1H, dd, J = 2.7,
7.7 Hz, H-3), 5.68 (1H, s, CHPh), 5.59 (1H, d, J = 0.9 Hz,
H-1), 4.64 (1H, ddd, J = 3.9, 6.9, 7.5, Hz, H-5), 4.39 (1H, dd,
J = 7.2, 7.5 Hz, H-4), 4.33 (1H, dd, J = 3.6, 7.8 Hz, H-6a),
3.96 (1H, dd, J = 7.5, 7.8 Hz, H-6b), 2.34 (3H, s, CH3).
13C
NMR (100 MHz, CDCl3): d 165.40, 165.29 (2 ¥ C = O), 138.
52, 138.03, 133.54, 133.11, 133.00, 130.07, 129.98, 129.84,
129.79, 129.57, 129.48, 129.10, 128.59, 128.27, 128.25,
126.19 (Ar), 101.96 (CHPh), 87.31 (C-1), 76.95 (C-4), 72.44
(C-2), 69.22 (C-3), 68.61 (C-6), 65.21 (C-5), 21.17 (CH3).
HR-MS: m/z 605.1604 [M + Na]
+ calculated for C34H30O7SNa,
found 605.1611.
p-Tolyl 2,3-Di-O-benzoyl-6-O-benzyl-1-thio-a-D-
mannopyranoside (7)
To an anhydrous CH2Cl2 (10 ml) solution of compound 6
(300 mg, 0.52 mmol) was added 200 mg of 4 Å molecular
sieves under an atmosphere of argon and cooled to -78°C.
Et3SiH (266 ml, 1.66 mmol) was added dropwise to the cooled
reaction mixture followed by addition of triﬂic acid (115 ml,
1.30 mmol). The reaction mixture was then stirred at -78°C
for 1 h. The reaction was quenched by the addition of triethy-
lamine (0.25 ml) and CH3OH (0.5 ml), diluted with CH2Cl2
(20 ml), and washed with saturated aqueous NaHCO3 solu-
tion (10 ml), H2O (10 ml) and brine (10 ml). The organic layer
was dried on Na2SO4, ﬁltered and the ﬁltrate concentrated to
a syrup. Flash chromatographic puriﬁcation of the crude
product using cyclohexane/ethyl acetate as eluent gave
pure 7 (241 mg, 80% yield) as colourless foam. Rf = 0.38
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1H NMR (CDCl3, 400 MHz):
d 8.03 (2H, m, Ar), 7.94 (2H, m, Ar), 7.58 (1H, m, Ar), 7.52
(1H, m, Ar), 7.43 (3H, m, Ar), 7.34 (8H, m, Ar), 7.08 (2H, d,
J = 6.0 Hz, Ar), 5.85 (1H, dd, J = 0.9, 2.2 Hz, H-2), 5.61 (1H,
d, J = 0.9 Hz, H-1), 5.57 (1H, dd, J = 2.2, 7.2 Hz, H-3), 4.69
(1H, d, J = 9.0 Hz, CH2Ph
a), 4.59 (1H, d, J = 9.0 Hz, CH2Ph
b),
4.53 (1H, m, H-5), 4.40 (1H, ddd, J = 2.7, 7.2, 7.5 Hz, H-4),
3.98 (1H, dd, J = 3.5, 7.8 Hz, H-6a), 3.89 (1H, dd, J = 2.7,
7.8 Hz, H-6b), 2.81 (1H, d, J = 3.0 Hz, 4-OH), 2.31 (3H,
s, CH3).
13C NMR (100 MHz, CDCl3): d 166.51, 165.37
(2 ¥ C = O), 138.18, 138.04, 133.43, 133.38, 132.68, 129.93,
129.88, 129.85, 129.53, 129.41, 129.32, 128.53, 128.41,
128.39, 127.68, 127.60 (Ar), 86.42 (C-1), 73.76 (CH2Ph),
73.18 (C-3), 72.44 (C-5), 72.01 (C-2), 68.99 (C-6), 67.80
(C-4), 21.14 (CH3). HR-MS: m/z 607.1761 [M + Na]
+ calcu-
lated for C34H32O7SNa, found 607.1757.
p-Tolyl 4-O-Acetyl-2,3-di-O-benzoyl-6-O-benzyl-1-thio-a-
D-mannopyranoside (4)
Compound 7 (200 mg, 0.34 mmol) was dissolved in 3 ml of
dry pyridine, and acetic anhydride (49 ml, 0.51 mmol) was
added under an argon atmosphere. The reaction mixture was
stirred for 5 h at room temperature, poured into an ice-water
mixture (10 ml) and extracted with CHCl3 (2 ¥ 15 ml). The
combined CHCl3 layers were washed with brine, dried over
Na2SO4 and concentrated. Flash chromatographic puriﬁca-
tion of the crude product using cyclohexane/ethyl acetate as
eluent gave pure 8 (202 mg, 94% yield) as colourless solid
(m.p. 93.7°C). Rf = 0.45 (cyclohexane/ethyl acetate, 2:1).
1H
NMR (CDCl3, 400 MHz): d 8.02 (2H, m, Ar), 7.91 (2H, m, Ar),
7.53 (2H, m, Ar), 7.45 (2H, m, Ar), 7.38 (2H, m, Ar), 7.32 (7H,
m, Ar), 7.07 (2H, d, J = 6.0 Hz, Ar), 5.87 (1H, dd, J = 1.5,
2.2 Hz, H-2), 5.81 (1H, t, J = 7.5 Hz, H-4), 5.65 (1H, dd,
J = 2.2, 7.3 Hz, H-3), 5.64 (1H, d, J = 1.5 Hz, H-1), 4.69 (1H,
m, H-5), 4.63 (1H, d, J = 8.7 Hz, CH2Ph
a), 4.51 (1H, d,
J = 8.7 Hz, CH2Ph
b), 3.75 (1H, dd, J = 3.4, 8.2 Hz, H-6a),
3.70 (1H, dd, J = 2.2, 8.2 Hz, H-6b), 2.30 (3H, s, PhCH3),
1.93 (3H, s, COCH3).
13C NMR (100 MHz, CDCl3): d 169.76
(COCH3), 165.47, 165.40 (2 ¥ COPh), 138.28, 137.99, 133.
42, 133.34, 132.74, 129.94, 129.91, 129.81, 129.31, 129.20,
129.12, 128.53, 128.46, 128.33, 127.80, 127.60 (Ar), 86.24
(C-1), 73.62 (CH2Ph), 71.88 (C-2), 70.95 (C-5), 70.68 (C-3),
68.93 (C-6), 66.85 (C-4), 21.14 (PhCH3), 20.76 (COCH3).
HR-MS: m/z 649.1867 [M + Na]
+ calculated for C36H34O8SNa,
found 649.1852.
1-Azidoethyl 4-O-Acetyl-2,3-di-O-benzoyl-6-O-benzyl-a-
D-mannopyranosyl-(1,6)-a-D-mannopyranosyl-(1,6)-
a-D-mannopyranosyl-(1,6)-2,3,4-tri-O-benzoyl-a-D-
mannopyranosyl-2,3,4-tri-O-benzoyl-a-D-
mannopyranosyl-(1,6)-2,3,4-tri-O-benzoyl-a-D-
mannopyranosyl-(1,6)-2,3,4-tri-O-benzoyl-a-D-
mannopyranosyl-(1,6)-2,3,4-tri-O-benzoyl-a-
D-mannopyranosyl-(1,6)-2,3,4-tri-O-benzoyl-a-D-
mannopyranoside (3)
To a solution of thiooctasaccharide 2 (150 mg, 0.04 mmol) in
dry CH2Cl2 (5 ml) were added the donor thioglycoside 4
(47 mg, 0.08 mmol) and 100 mg of 4 Å molecular sieves. The
mixture was cooled to -20°C and NIS (11.0 mg, 0.048 mmol)
and triﬂic acid (2 ml, 0.02 mmol) added and the reaction was
stirred for 15 min at -20°C. The temperature of the reaction
mixture was raised to room temperature and after 1 h, 5 ml of
saturated aqueous NaHCO3 was added. The reaction mix-
tures were extracted with 2 ¥ 10 ml of CHCl3 and the organic
layer was washed with saturated aqueous sodium thiosulfate
solution (5 ml). The organic layer was dried over Na2SO4 and
concentrated to a syrup. Flash chromatographic puriﬁcation
of the crude product was performed using cyclohexane/ethyl
acetate as eluent and gave pure nonasaccharide 3 (169 mg,
82% yield) as colourless solid (m.p. 202°C). Rf = 0.43
(cyclohexane/ethyl acetate, 1:1).
1H NMR (CDCl3, 400 MHz):
d 8.16 (15H, m,Ar), 8.05 (18H, m,Ar), 7.87 (17H, m,Ar), 7.47
(50H, m, Ar), 7.26 (35H, m, Ar), 6.18 (8H, m), 6.02 (2H, m),
5.98 (7H, m), 5.85 (3H, m), 5.26 (1H, s), 5.22 (1H, d,
J = 1.2 Hz), 4.96 (6H, m), 4.48 (1H, d, J = 11.9 Hz, CH2Ph
a),
4.57 (1H, dd, J = 1.8, 7.5 Hz), 4.38 (1H, dd, J = 2.4, 7.2 Hz),
4.28 (1H, d, J = 11.9 Hz, CH2Ph
b), 4.13 (8H, m), 3.86 (9H, m),
3.66 (1H, dd, J = 2.1, 8.4 Hz), 3.57 (4H, m), 3.37 (7H, m),
1.88 (3H, s, CH3).
13C NMR (100 MHz, CDCl3): d 166.79
(COCH3), 165.72, 165.56, 165.54, 165.52, 165.45, 165.37,
165.35, 165.33, 165.25, 165.23, 165.11 (COPh), 133.72,
133.51, 133.44, 133.29, 133.05, 132.96, 130.06, 130.01,
129.86, 129.67, 129.48, 129.42, 129.40, 129.37, 129.28,
129.21, 129.18, 129.15, 129.05, 128.82, 128.78, 128.70,
128.60, 128.51, 128.38, 128.27 (Ar), 98.28, 98.09, 97.95,
97.87 (C-1’s), 73.45 (OCH2Ph), 70.88, 70.61, 70.53, 70.39,
70.29, 70.25, 70.17, 69.90, 69.71, 69.63, 69.54, 69.47, 69.40,
69.30, 67.19, 67.12, 66.74, 66.41, 66.32, 66.24, 66.03, 65.96,
65.75, 50.48 (CH2N3), 20.81 (COCH3).
1-Azidoethyl
6-O-Benzyl-a-D-mannopyranosyl-(1,6)-2,3,4-tri-O-
benzoyl-a-D-mannopyranosyl-(1,6)-a-D-
mannopyranosyl-(1,6)-a-D-mannopyranosyl-a-D-
mannopyranosyl-(1,6)-a-D-mannopyranosyl-(1,6)-a-
D-mannopyranosyl-(1,6)-a-D-mannopyranosyl-(1,6)-
a-D-mannopyranoside (1)
To an ice-cooled solution of compound 3 (150 mg,
0.03 mmol) in dry CH2Cl2–CH3OH (1:2, 10 ml) was added a
sodium methoxide solution in CH3OH (25% w/v, 2.0 ml). The
reaction mixture was allowed to stir overnight at room tem-
perature and H
+ Amberlite resin (200 mg) was added. It was
ﬁltered, solvent was evaporated and the residue was washed
with CHCl3 (3 ¥ 10 ml). An aqueous solution (2 ml) crude
nonasaccharide was passed through a small column of Bio-
Beads SM-4 (15 g, 20–50 mesh) and eluted with 0–60%
CH3OH–H2O. The aqueous solution that remained after brief
evaporation under vacuum was frozen and lyophilized to a
colourless foam (19 mg, 35%).
1H NMR (CDCl3, 400 MHz): d
7.68 (1H, m), Ar), 7.38 (4H, m, Ar), 4.89 (1H, s), 4.64 (1H, d,
J = 11.6 Hz, OCH2Ph), 4.61 (1H, d, J = 11.7 Hz, OCH2Ph),
3.99–3.60 (63H, m), 2.68 (2H, m, CH2N3).
13C NMR
(100 MHz, CDCl3): d 138.04, 128.39, 128.37, 127.01 (Ar),
101.77, 101.04, 100.96, 100.72, 100.55 (C-1’s), 74.48, 74.37,
73.32 (OCH2Ph), 73.18, 72.86, 72.77, 72.62, 72.56, 72.42,
72.04, 70.97, 68.84, 68.71, 68.56, 67.86, 67.45, 67.31, 67.00,
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+ calculated
for C63H101N3O46Na, found 1658.5503.
In vitro a(1,2)-mannopyranosyltransferase assay
utilizing a novel nonasaccharide acceptor, Acc-Man9
Corynebacterium glutamicum, C. glutamicumDmptC, C.
glutamicumDmptD, complemented strains, and a double
mutant devoid of Manp branching activities (MptC and MptD)
were used to characterize the enzymatic activity of Cg-MptC
and Cg-MptD, and Mt-Rv2181. Membranes from all strains of
C. glutamicum were prepared as described previously
(Mishra et al., 2008a) and resuspended in 100 mM sodium
acetate (pH 6.0), containing 5 mM b-mercaptoethanol and
7 mM MgCl2 (Buffer E) to a ﬁnal concentration of
10–15 mg ml
-1. The chemically synthesized nonasaccharide
acceptor, azidoethyl 6-O-benzyl-a-D-mannopyranosyl-
(1→6)-[a-D-mannopyranosyl-(1→6)]7-D-mannopyranoside
(Acc-Man9), and PP-[
14C]-M [Gurcha et al., 2002; stored in
CHCl3/CH3OH, 2:1, v/v], were aliquoted into 1.5 ml Eppendorf
tubes to a ﬁnal concentration of 2 mM and 250 000 cpm
(0.305 Ci mmol
-1), respectively, and dried under nitrogen.
IgePal CA-630 (8 ml, SigmaAldrich) was added and the tubes
sonicated to resuspend the lipid linked components, and
1 mMATP, 1 mM NADP, 5 mM MnCl2, and membrane protein
(1 mg) added to a ﬁnal volume of 100 ml. The reaction mixture
incubatedat37°Cfor2 hasdescribed(YokoyamaandBallou,
1989) and then terminated by the addition of 5 ml of 50%
C2H5OH. The supernatant was recovered, dried and resus-
pended in 700 ml of water and loaded onto a 1 ml strong anion
exchange SepPak cartridge (Supelco). The cartridge washed
with H2O (5 ml), which was collected, dried and resuspended
in 200 mlo fH 2O and 10% of the reaction product was quan-
tiﬁed by scintillation counting using 5 ml of Ecolume (ICN
Biomedicals, Costa Mesa, CA, USA) and the remaining mate-
rial analysed by 15% SDS-PAGE-/autoradiography as
described previously (Mishra et al., 2008a).
Acc-Man9-[14C]-Manx and selective cleavage by an
a(1,2)-D-mannosidase
The extracted Acc-Man9-[
14C]-Manx products from the assays
performed with C. glutamicum membranes were dried and
subsequently incubated at 30°C for 24 h in 0.1 M acetate
buffer, pH 5.0, with 5 mU of a(1→2)-D-mannosidase
(Maras et al., 2000) as described previously (Ichishima et al.,
1981; Yokoyama and Ballou, 1989). The reaction mixture was
fractionated on a 50 ml Bio-Gel P-2 gel ﬁltration
column (30 cm ¥ 1.5 cm; Bio-Rad) in H2O. The control
Acc-Man9-[
14C]-Manx before a(1→2)-D-mannosidase treat-
ment eluted form the Bio-Gel P-2 column at fractions 11–13,
and digested products (release of [
14C]Manp) was retained
and eluted in later fractions 33–39 based on a [
14C]-mannose
standard (Cooper et al., 2002).
Cell stimulation assays
Trypsine-released HEK293 cells were washed with and
resuspended in culture medium at 1.11 ¥ 10
6 cells ml
-1. Cells
(1 ¥ 10
5,9 0ml) were transferred to a 96-well U-bottom plate
(Greiner) and left for 2 h to let the cells re-adhere. After this,
cells were stimulated (in triplicate) with 50 mgm l
-1 wild-type or
mutant Cg-LM and Cg-LAM (pretreated with 1% hydrogen
peroxide for 96 h as described (Birch et al., 2010) in a ﬁnal
stimulation volume of 100 ml. Unstimulated cells served as a
control. Culture supernatants were harvested after 24 h by
centrifugation and stored at -80°C for cytokine measure-
ments using enzyme-linked immunosorbent assay (ELISA)
against human IL-8 (Invitrogen).
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